Welcome

Translational Cancer

Translational Immunology, Inflammation and Infection

Genomics of Human Disease

Nanomedicine and Key Enabling Technologies

Next Generation Sequencing

Flow Cytometry Facility

High Content Analysis

Advanced Materials

TTMI Transition Year Programme March 2nd - 6th, 2026

TTMI will host the annual Translational Medicine Transition Year Programme. This full-time, 1-week course includes lectures, demonstrations, tours, and hands-on experiments led by Trinity College academics and researchers.

Ireland takes significant step towards strengthening collaboration with EATRIS

TTMI and EATRIS-ERIC are pleased to announce the signing of an MoU to foster collaboration and coordination in promoting the benefits of Ireland’s potential membership in EATRIS-ERIC

Translational Medicine Alliance Ireland (TMAI)

TMAI is organised as a decentralised collaborative alliance of 10 Irish Universities that will catalyse the development of productive translational research collaborations under one umbrella.

€4.8M investment in Trinity COVID-19 Immunology Research hub

The Trinity COVID-19 Immunology Research hub seeks to utilize its world-class immunology expertise to provide research-based solutions to tackle the COVID-19 pandemic

€10.5M programme to develop next generation cell therapies for cancer

Researchers at TTMI are part of a successful consortium to secure €6.8M government funding as part of a 3-year, €10.5M programme to develop next generation cell therapies for cancer

€7.2M programme delivers next gen gene therapies for gastrointestinal cancer

TTMI researchers are part of a successful consortiuma planning to invest €7.2 million in developing a better way to treat gastrointestinal cancer